Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
US |
|
A
|
Aeluma Inc
OTC:ALMU
|
US |
|
Gerdau SA
BOVESPA:GGBR4
|
BR |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
Banca Popolare Di Sondrio SpA
MIL:BPSO
|
IT |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
P
|
PDD Holdings Inc
SWB:9PDA
|
IE |
|
S
|
Strawberry Fields Reit Inc
AMEX:STRW
|
US |
|
Housing Development Finance Corporation Ltd
NSE:HDFC
|
IN |
|
F
|
First Watch Restaurant Group Inc
NASDAQ:FWRG
|
US |
|
Rumble Inc
NASDAQ:RUM
|
US |
|
Hyundai Glovis Co Ltd
KRX:086280
|
KR |
|
Tyra Biosciences Inc
NASDAQ:TYRA
|
US |
Bankruptcy Probability
Tarsus Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Tarsus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
542.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
293.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
225.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
245.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Tarsus Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Tarsus Pharmaceuticals Inc has total debt of 72.6m USD. This includes both short-term (0 USD) and long-term (72.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
